Gastroesophageal reflux disease (GERD) is a set of conditions in which stomach acid or bile irritates the food pipe lining. In GERD, weak or inappropriately relaxed lower esophageal sphincter allows the contents of the stomach to flow up into the esophagus. Hiatal hernia may also lead to GERD. The superior part of the stomach shifts up into the chest by a small opening in the diaphragmatic hiatus or the diaphragm in hiatal hernia. Several recent studies have demonstrated that the aperture in the diaphragm supports the anterior end of the esophagus. Although majority of people suffering from hiatal hernia may not have issues with reflux, the stomach contents may reflux straightforwardly into the esophagus.
Get Free Sample Copy at: https://www.coherentmarketinsights.com/insight/request-pdf/159
Based on the severity of the disease, there are two approaches for the treatment of GERD that include:
- Primary Stage: Use of antacids, H2-receptor antagonists, and changes in diet and lifestyle
- Failure to react to above treatment options: Exposure to Proton Pump Inhibitors
Linx, Esophy X, and Endocinch endoluminal gastroplication are some of the invasive methods and Stretta technique is a noninvasive technique.
Esophagogastroduodenoscopy, Barium esophagram, and manometry is used in the diagnosis of GERD.
Global Gastroesophageal Reflux Disease (GERD) Treatment Devices Market: Drivers
Increasing prevalence of GERD is expected to boost growth of the global gastroesophageal reflux disease (GERD) treatment devices market over the forecast period. For instance, according to a report by Florida Hospital, presently, about 60 million adults in the U.S. suffer from GERD every month, of which 25 million suffer from symptoms each day. Moreover, around 20% of people with gastroesophageal reflux may develop GERD.
Increasing investment in R&D in the treatment of GERD is also expected to boost growth of the global gastroesophageal reflux disease (GERD) treatment devices market. Healthcare professionals are increasingly adopting treatment devices as they have high precision rate and minimal side effects. For instance, the U.S. FDA granted breakthrough device designation to AI Medical Service’s artificial intelligence technology for diagnosis of gastric cancer and other gastroesophageal diseases.
Increasing R&D in e diagnosis and treatment of GERD is expected to boost growth of the market. For instance, in August 2019, researchers from Kiryu University, Japan, reported development of an organ-specific chronic inflammation–remodeling–carcinoma sequence for use in the treatment of GERD, in the journal MDPI Gastrointestinal Disorders. In February 2019, EndoGastric Solutions announced improved PH rates and clinical outcomes in patients with gastroesophageal reflux disease in a clinical trial of a transoral incisionless fundoplication (TIF) 2.0 procedure using its EsophyX device. Moreover, in November 2018, researchers from Massachusetts Institute of Technology reported development of a computer-aided algorithm and to assess the characteristics of subsurface hyposcattering structures in Barrett’s esophagus, a complication of chronic gastroesophageal reflux disease using clinical volumetric laser endomicroscopy data.
Increasing geriatric population is expected to boost growth of the global gastroesophageal reflux disease (GERD) treatment devices market. For instance, according to Health line, pregnant women and persons above the age of 40 years are at a higher risk of gastroesophageal disease and 25% of pregnant women experience symptoms of the disease. According to the same source, around 65% of patients who suffer from acid refluxes are 40 years of age or older.
However, several studies have associated the diagnostic endoscopic procedure esophagogastroduodenoscopy (EGD) with a false negative rates, which is expected to hinder growth of the market. Moreover, security risks of esophageal manometry (HRM) medical devices is also expected to hamper the market growth. For instance, in August 2019, The Veterans Affairs Office of Inspector General found that high-resolution esophageal manometry (HRM) medical device stopped interfacing with the VHA HER after a computer update at the Tibor Rubin VA Medical Center in Long Beach, California.
Global Gastroesophageal Reflux Disease (GERD) Treatment Devices Market Taxonomy
On the basis of surgery type, global gastroesophageal reflux disease (GERD) treatment devices market is segmented into:
- Medigus Ultrasonic Surgical Endostapler
- Linx Reflux Management
- Endocinch Endolumminal gastroplication
- Endoscopic Plicator System
- Plexiglas poly-methyl-methacrylate (PMMA) microspheres
On the basis of end user, the global gastroesophageal reflux disease (GERD) treatment devices market is segmented into:
- Medical Practitioners
On the basis of region, the global gastroesophageal reflux disease (GERD) treatment devices market is segmented into:
- North America
- Latin America
- Asia Pacific
- Middle East
Purchase a copy of Gastroesophageal Reflux Disease Treatment Devices Market Report: https://www.coherentmarketinsights.com/insight/buy-now/159
Global Gastroesophageal Reflux Disease (GERD) Treatment Devices Market: Regional Analysis
North America is expected to witness significant growth in the global gastroesophageal reflux disease (GERD) treatment devices market over the forecast period. This is attributed to high prevalence of GERD in the region.
Global Gastroesophageal Reflux Disease (GERD) Treatment Devices Market: Competitive Landscape
Major players operating in the global gastroesophageal reflux disease (GERD) treatment devices market include, Torax Medical, Inc., EndoGastric Solutions, C. R. Bard, Inc., Mederi Therapeutics Inc., and Medigus Ltd.
Key players in the market are focused on raising funds. For instance, in May 2019, EndoGastric Solutions closed its Series I financing at a total of US$ 45 million. The company intends to use the funds to accelerate commercialization of Transoral Incisionless Fundoplication procedure performed with the EsophyX device.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Other Related Market Research Reports:
- Bioimplants Market – https://www.coherentmarketinsights.com/ongoing-insight/bioimplants-market-3050
- Specimen Retrieval Market – https://www.coherentmarketinsights.com/ongoing-insight/specimen-retrieval-market-3022
Name: Mr. Raj Shah
Phone: US +12067016702
Country: United States
Visit Blog: https://globalindustryresearchblog.wordpress.com/